Clinical Trial Update: Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical cannabidiol for chemotherapy-induced peripheral neuropathy has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Malignant Solid Neoplasm

Drugs mentioned

• Topical cannabidiol (cannabidiol)

Snippet

Sponsor: Mayo Clinic | Conditions: Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2026-01-16